Security Snapshot

ALIMERA SCIENCES INC - COM (ALIM) Institutional Ownership

CUSIP: 016259103

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2020

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • ALIM - ALIMERA SCIENCES INC - COM is tracked under CUSIP 016259103.
  • Latest finished 13F holder period is not available.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 1 to 1 between Q3 2020 and Q4 2020.
  • SEC-reported value moved from $390,000 to $752,000.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

016259103

Latest holder period

n/a

13F holders

13D/G owners

0

CIK / CUSIP context first

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
28
Latest
n/a
Rows shown
1-25 of 28
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2020 Q4 178,259 $752,000 -$390,000 $4.22 1
2020 Q3 80,194 $390,000 $4.86 1
2020 Q2 80,194 $505,000 -$772,514 $6.30 1
2020 Q1 276,113 $1,105,000 +$301,000 $4.00 2
2019 Q4 200,919 $1,523,000 -$38,443,061 $7.58 1
2019 Q3 33,246,163 $18,828,003 -$1,574,035 $0.57 30
2019 Q2 35,812,803 $31,874,004 -$284,756 $0.89 37
2019 Q1 36,058,911 $38,223,005 +$495,839 $1.06 35
2018 Q4 35,704,061 $25,639,004 -$727,712 $0.72 35
2018 Q3 36,629,143 $35,895,005 +$227,721 $0.98 39
2018 Q2 36,305,578 $35,515,005 +$1,505,672 $0.98 33
2018 Q1 34,753,116 $35,795,005 +$2,529,463 $1.03 37
2017 Q4 32,277,175 $42,928,007 +$4,470,256 $1.33 37
2017 Q3 28,882,743 $38,988,007 +$4,368,536 $1.35 37
2017 Q2 25,684,766 $35,701,007 -$3,612,846 $1.39 36
2017 Q1 28,294,355 $39,607,007 -$1,933,128 $1.40 36
2016 Q4 31,070,678 $33,552,005 +$129,765 $1.08 44
2016 Q3 37,701,221 $56,174,007 +$15,381,791 $1.49 51
2016 Q2 27,480,403 $33,795,006 -$3,160,333 $1.23 47
2016 Q1 29,822,152 $52,184,000 -$959,330 $1.75 50
2015 Q4 29,943,317 $72,466,572 -$1,949,391 $2.42 61
2015 Q3 30,942,736 $68,370,693 -$21,348 $2.21 59
2015 Q2 30,618,924 $141,413,822 +$1,909,411 $4.61 61
2015 Q1 30,180,004 $151,204,746 -$475,219 $5.01 63
2014 Q4 30,221,413 $167,076,344 +$7,646,445 $5.54 65
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .